Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-10-29
RXRXRecursion Pharmaceuticals, Inc.Borgeson BlakeDirS - Sale$6.72-11,4477,077,5600%-$76,926
2024-10-31
SCLXScilex Holding CoJi HenryExec ChairpersonP - Purchase$0.94+8,888680,884+1%+$8,351
2024-10-28
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale$28.39-25,000581,324-4%-$709,750
M
2024-10-28
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$9.44-157,8955,652,922-3%-$1,491,041
2024-10-28
RLAYRelay Therapeutics, Inc.Rahmer PeterSee remarksS - Sale$6.06-1,621390,0630%-$9,823
M
2024-10-28
RLAYRelay Therapeutics, Inc.Catinazzo ThomasCFOS - Sale$6.03-9,102304,091-3%-$54,905
2024-10-28
RLAYRelay Therapeutics, Inc.Bergstrom Donald APres, R, DS - Sale$6.06-2,688520,745-1%-$16,289
2024-10-28
RLAYRelay Therapeutics, Inc.Adams BrianGCS - Sale$6.06-1,632321,907-1%-$9,890
2024-10-29
AURAAura Biosciences, Inc.De Los Pinos ElisabetSee RemarksS - Sale$10.74-9,200452,059-2%-$98,788
2024-10-29
AURAAura Biosciences, Inc.Elazzouzi AmyVP, FinanceS - Sale$10.74-55339,443-1%-$5,938
2024-10-29
SCLXScilex Holding CoShah JaisimSee RemarksP - Purchase$0.99+32,000265,215+14%+$31,670
D
2024-10-24
RXRXRecursion Pharmaceuticals, Inc.Marriott TinaPres, COOS - Sale+OE$6.31-6,000521,138-1%-$37,855
2024-10-23
IMVTImmunovant, Inc.Levine Mark S.GCS - Sale$29.53-4,361322,878-1%-$128,780
2024-10-23
IMVTImmunovant, Inc.Geffner MichaelChief Medical OfficerS - Sale$29.53-3,189134,971-2%-$94,171
2024-10-23
IMVTImmunovant, Inc.Stout Jay SCTOS - Sale$29.53-2,740142,186-2%-$80,912
2024-10-23
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$43.09-2,261159,483-1%-$97,429
2024-10-22
TECXTectonic Therapeutic, Inc.Springer Timothy ADir, 10%P - Purchase$33.59+300,0004,593,121+7%+$10,077,000
D
2024-10-21
IKTInhibikase Therapeutics, Inc.Bellini RobertoDirP - Purchase$1.37+1,460,0001,460,000New+$2,000,200
D
2024-10-21
IKTInhibikase Therapeutics, Inc.Kush ArvindDirP - Purchase$1.37+145,000145,000New+$198,650
D
2024-10-21
IKTInhibikase Therapeutics, Inc.Munshi AmitDirP - Purchase$1.37+365,000365,000New+$500,050
M
2024-10-21
ALVRAllovir, Inc.Sinha VikasSee Remarks, 10%S - Sale$0.77-3,42817,823,9820%-$2,649
2024-10-21
ALVRAllovir, Inc.Brainard DianaCEOS - Sale$0.78-9,752742,678-1%-$7,597
M
2024-10-21
ALVRAllovir, Inc.Hagen Brett RChief Accounting OfficerS - Sale$0.77-96570,715-1%-$746
M
2024-10-21
ALVRAllovir, Inc.Miller EdwardGCS - Sale$0.77-1,401503,0020%-$1,083
D
2024-10-22
ACLXArcellx, Inc.Patel KavitaDirS - Sale+OE$89.69-1,5000-100%-$134,535
D
2024-10-18
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale+OE$27.69-40,0002,438,411-2%-$1,107,600
D
2024-10-18
PCVXVaxcyte, Inc.Guggenhime AndrewPres, CFOS - Sale+OE$115.39-42,00090,383-32%-$4,846,508
D
2024-10-21
SLDBSolid Biosciences Inc.Brooks GabrielChief Medical OfficerS - Sale+OE$6.50-2,92310,979-21%-$19,000
D
2024-10-18
AURAAura Biosciences, Inc.Feder Julie BCFOS - Sale+OE$12.03-25,131134,276-16%-$302,361
2024-10-17
TVGNTevogen Bio Holdings Inc.Flomenberg NealSee RemarksS - Sale$1.62-1,078,6004,254,302-20%-$1,747,332
D
2024-10-18
AURAAura Biosciences, Inc.De Los Pinos ElisabetSee RemarksS - Sale+OE$12.04-24,992461,259-5%-$300,839
DM
2024-10-17
NMRANeumora Therapeutics, Inc.Fust Matthew KDirS - Sale+OE$17.03-21,78820,100-52%-$370,962
2024-10-16
IMVTImmunovant, Inc.Salzmann PeterCEOS - Sale$28.79-9,095994,789-1%-$261,845
2024-10-16
IMVTImmunovant, Inc.Macias William L.Chief Medical OfficerS - Sale$28.79-3,188365,144-1%-$91,783
2024-10-18
SCLXScilex Holding CoFollowwill DormanDirP - Purchase$0.99+1,0002,300+77%+$990
2024-10-18
SCLXScilex Holding CoChun JayDirP - Purchase$0.95+5,000112,511+5%+$4,750
2024-10-16
IMVTImmunovant, Inc.Levine Mark S.GCS - Sale$28.79-2,860327,239-1%-$82,339
2024-10-16
IMVTImmunovant, Inc.Barnett Eva ReneeCFOS - Sale$28.79-3,271335,343-1%-$94,172
M
2023-12-27
ENGNEngene Holdings Inc.Forbion Growth Opportunities Fund I Cooperatief U.A.10%P - Purchase$6.40+470,6336,236,565+8%+$3,012,674
DM
2024-10-16
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$40.86-35,000220,937-14%-$1,430,100
D
2024-10-16
VCELVericel CorpGilman Steven CDirS - Sale+OE$41.36-5,83311,000-35%-$241,253
2024-10-17
SCLXScilex Holding CoWu Yue AlexanderDirP - Purchase$0.95+20,00025,000+400%+$18,992
2024-10-17
SCLXScilex Holding CoLemus DavidDirP - Purchase$0.90+2,0002,000New+$1,800
2024-10-17
SCLXScilex Holding CoJi HenryExec ChairpersonP - Purchase$0.97+10,000671,996+2%+$9,710
D
2024-10-16
ZIVOZivo Bioscience, Inc.Yaldoo Laith LDirP - Purchase$15.96+3,133533,424+1%+$49,993
2024-10-15
RXRXRecursion Pharmaceuticals, Inc.Borgeson BlakeDirS - Sale$6.67-11,4477,089,0070%-$76,326
2024-10-16
SCLXScilex Holding CoShah JaisimSee RemarksP - Purchase$0.99+30,000233,215+15%+$29,751
2024-10-16
SCLXScilex Holding CoMa Stephen HoiCFOP - Purchase$0.97+6,70022,840+42%+$6,499
2024-10-16
AURAAura Biosciences, Inc.Plavsic MarkCTOS - Sale$9.85-7,383121,132-6%-$72,723
DM
2024-10-15
HALOHalozyme Therapeutics, Inc.Labarre Michael J.SVP, CHIEF TECHNICAL OFFICERS - Sale+OE$53.50-20,000173,756-10%-$1,070,059
2024-10-15
XFORX4 Pharmaceuticals, IncRagan PaulaPres, CEOS - Sale$0.56-31,8971,025,816-3%-$17,926
D
2024-10-14
BEAMBeam Therapeutics Inc.Ciaramella GiuseppePresS - Sale+OE$26.27-51,110160,260-24%-$1,342,752
D
2024-10-14
RVMDRevolution Medicines, Inc.Kelsey Stephen MichaelSee RemarksS - Sale+OE$49.49-16,666264,408-6%-$824,804
D
2024-10-16
ZIVOZivo Bioscience, Inc.Payne John BernardPres, CEOP - Purchase$15.76+6,3437,909+405%+$99,966
D
2024-10-14
CRSPCrispr Therapeutics AGKasinger James R.GC, SecretaryS - Sale+OE$46.28-1,08962,597-2%-$50,399
D
2024-10-14
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$46.28-4,293312,162-1%-$198,680
M
2024-10-11
CADLCandel Therapeutics, Inc.Aguilar-Cordova Estuardo10%S - Sale$6.03-40,4126,053,781-1%-$243,834
D
2024-10-11
RVMDRevolution Medicines, Inc.Horn Margaret ACOOS - Sale+OE$50.34-50,000132,320-27%-$2,517,055
D
2024-10-11
RVMDRevolution Medicines, Inc.Goldsmith Mark ASee RemarksS - Sale+OE$50.36-30,000816,622-4%-$1,510,773
D
2024-10-11
RVMDRevolution Medicines, Inc.Anders JackCFOS - Sale+OE$50.30-10,00098,932-9%-$502,979
D
2024-10-11
RVMDRevolution Medicines, Inc.Cislini JeffGCS - Sale+OE$50.17-6,00045,634-12%-$301,027
D
2024-10-10
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale+OE$8.10-5,000120,695-4%-$40,496
M
2024-10-09
NMRANeumora Therapeutics, Inc.Lenz Robert A.Head of R, DS - Sale$15.06-13,823314,706-4%-$208,110
2024-10-09
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$41.81-85673,397-1%-$35,791
2024-10-09
IMVTImmunovant, Inc.Barnett Eva ReneeCFOS - Sale$29.56-5,162338,614-2%-$152,589
2024-10-09
IMVTImmunovant, Inc.Salzmann PeterCEOS - Sale$29.56-4,4601,003,8840%-$131,838
DM
2024-10-08
RXRXRecursion Pharmaceuticals, Inc.Secora MichaelCFOS - Sale+OE$6.34-30,0001,450,881-2%-$190,131
D
2024-10-08
SRRKScholar Rock Holding CorpMyles Edward HCOO, CFOS - Sale+OE$34.90-37,187161,088-19%-$1,297,659
D
2024-10-08
FENCFennec Pharmaceuticals Inc.Rallis Chris ADirS - Sale+OE$4.53-1,40648,623-3%-$6,369
2024-10-08
RVMDRevolution Medicines, Inc.Weber BarbaraDirS - Sale$48.02-5,20013,065-28%-$249,716
DM
2024-10-08
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$53.29-20,000676,744-3%-$1,065,743
2024-10-08
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$0.91+5,4318,639+169%+$4,942
2024-10-07
PCVXVaxcyte, Inc.Pickering GrantCEOS - Sale$109.21-7,098588,800-1%-$775,154
D
2024-10-07
PCVXVaxcyte, Inc.Eydelman MikhailSVP, GC, Corp SecS - Sale+OE$109.27-5,00028,623-15%-$546,353
2024-10-07
XFORX4 Pharmaceuticals, IncMostafa Adam S.CFOS - Sale$0.55-230,6450-100%-$126,901
2024-10-07
XFORX4 Pharmaceuticals, IncBaldry MarkChief Commercial OfficerS - Sale$0.58-11,12748,509-19%-$6,506
2024-10-07
XFORX4 Pharmaceuticals, IncRagan PaulaPres, CEOS - Sale$0.55-239,4361,057,713-18%-$131,522
2024-10-07
XFORX4 Pharmaceuticals, IncDibiase MaryCOOS - Sale$0.57-67,695452,060-13%-$38,329
2024-10-07
XFORX4 Pharmaceuticals, IncTaveras ArthurChief Scientific OfficerS - Sale$0.56-76,920388,026-17%-$43,306
D
2024-10-04
DNAGinkgo Bioworks Holdings, Inc.Coen Steven P.See remarksS - Sale+OE$8.35-3066,046-5%-$2,555
D
2024-10-04
DNAGinkgo Bioworks Holdings, Inc.Dmytruk Mark E.See RemarksS - Sale+OE$8.35-1,21730,237-4%-$10,163
D
2024-10-07
MRNAModerna, Inc.Mock James MCFOS - Sale+OE$60.12-7159,505-7%-$42,986
D
2024-10-07
SRRKScholar Rock Holding CorpMyles Edward HCOO, CFOS - Sale+OE$26.56-206,240161,088-56%-$5,477,546
D
2024-10-07
SRRKScholar Rock Holding CorpSacco TraceyCHIEF COMMERCIAL OFFICERS - Sale+OE$25.62-30,00049,285-38%-$768,677
2024-10-07
SRRKScholar Rock Holding CorpAkkaraju SrinivasDirS - Sale$29.25-1,175,71311,905,005-9%-$34,385,673
D
2024-10-07
SRRKScholar Rock Holding CorpMarantz Jing L.Chief Medical OfficerS - Sale+OE$27.21-109,37572,855-60%-$2,976,468
2024-10-02
APGEApogee Therapeutics, Inc.Dambkowski CarlChief Medical OfficerS - Sale$56.26-6,665274,128-2%-$374,954
2024-10-02
APGEApogee Therapeutics, Inc.Henderson Michael ThomasCEOS - Sale$56.23-40,0001,354,487-3%-$2,249,307
DM
2024-10-02
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$6.12-40,000762,656-5%-$244,800
2024-10-03
ALVRAllovir, Inc.Sinha VikasSee Remarks, 10%S - Sale$0.81-94017,827,4100%-$766
2024-10-03
ALVRAllovir, Inc.Miller EdwardGCS - Sale$0.81-377504,4030%-$307
2024-10-03
ALVRAllovir, Inc.Brainard DianaCEOS - Sale$0.81-1,493752,4300%-$1,216
2024-10-03
ALVRAllovir, Inc.Hagen Brett RChief Accounting OfficerS - Sale$0.81-30171,6800%-$245
D
2024-10-02
VCELVericel CorpGilman Steven CDirS - Sale+OE$40.35-5,83311,000-35%-$235,362
2024-10-02
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$43.21-3,31084,585-4%-$143,028
D
2024-10-02
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$43.21-13,605481,918-3%-$587,886
2024-10-02
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$43.21-6,865161,744-4%-$296,644
2024-10-02
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$43.21-3,10475,289-4%-$134,127
M
2024-10-01
CADLCandel Therapeutics, Inc.Aguilar-Cordova Estuardo10%S - Sale$6.93-35,0026,094,193-1%-$242,642
2024-10-01
RXRXRecursion Pharmaceuticals, Inc.Borgeson BlakeDirS - Sale$6.22-11,4477,098,4280%-$71,150

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top